Transcriptomics

Dataset Information

3

Transcription profiling of mouse APP transgenic mouse model of Alzheimers disease treated with BDNF


ABSTRACT: We examined transgenic (TG) mice expressing human APP695 bearing the double Swedish (671KM>NL) and Indiana (717V>F) amyloid precursor protein (APP) mutations. Lentiviral vectors constitutively expressing BDNF-GFP under control of the CMV/ß-actin hybrid promoter or GFP alone were injected into the entorhinal cortices of TG mice bilaterally at age 6 months, a time point by which neuropathological degeneration and cell loss are established. Age-matched wild-type littermates underwent sham surgery or injection of lentivirus expressing GFP into the entorhinal cortices bilaterally. Experiment Overall Design: 26 Samples total: 4 biological replicates of APP transgenic mice BDNF treated, 4 biological replicates of APP transgenic mice GFP treated, 3 biological replicates of non-trangenic mice sham lesion and 2 biological replicates of non-transgenic mice GFP treated for both tissues: Entorhinal cortex and hippocampus.

INSTRUMENT(S): 418 [Affymetrix]

ORGANISM(S): Mus musculus  

SUBMITTER: Giovanni Coppola  

PROVIDER: E-GEOD-14499 | ArrayExpress | 2009-02-01

SECONDARY ACCESSION(S): GSE14499PRJNA114487

REPOSITORIES: GEO, ArrayExpress

Similar Datasets

2009-01-23 | GSE14499 | GEO
2016-01-01 | S-EPMC5080538 | BioStudies
2017-01-01 | S-EPMC5359257 | BioStudies
1000-01-01 | S-EPMC5504055 | BioStudies
2017-01-01 | S-EPMC5489377 | BioStudies
2007-01-01 | S-EPMC6673566 | BioStudies
1000-01-01 | S-EPMC5445699 | BioStudies
2009-01-01 | S-EPMC3049872 | BioStudies
2009-01-01 | S-EPMC2838375 | BioStudies
2012-01-01 | S-EPMC3897235 | BioStudies